Incanthera (INC) 주식 개요피부과 및 종양학 치료제 회사인 Incanthera plc는 다양한 적응증에 대한 피부과 제형 및 전달 기술에 중점을 두고 있습니다. 자세히 보기INC 펀더멘털 분석스노우플레이크 점수가치 평가1/6미래 성장0/6과거 실적0/6재무 건전성4/6배당0/6위험 분석지난 5년간 매년 수익이 17.9% 감소했습니다.수익이 USD$1m 미만입니다(£6K)cash runway 경력이 1년 미만입니다.지난 3개월 동안 주가 변동성이 UK 시장과 비교했을 때 매우 높았습니다.+ 위험 2건 추가모든 위험 점검 보기INC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUK£Current PriceUK£0.018414.7% 고평가 내재 할인율Est. Revenue$PastFuture-8m302k2016201920222025202620282031Revenue UK£219.7kEarnings UK£32.2kAdvancedSet Fair ValueView all narrativesIncanthera plc 경쟁사Thalia TherapeuticsSymbol: AIM:THATMarket cap: UK£5.4mFutura MedicalSymbol: AIM:FUMMarket cap: UK£2.9mNuformixSymbol: LSE:NFXMarket cap: UK£4.8mSareum HoldingsSymbol: AIM:SARMarket cap: UK£29.1m가격 이력 및 성과Incanthera 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가UK£0.01852주 최고가UK£052주 최저가UK£0베타0.641개월 변동37.25%3개월 변동16.67%1년 변동-53.33%3년 변동-73.28%5년 변동-86.11%IPO 이후 변동-83.33%최근 뉴스 및 업데이트New Risk • Jun 29New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$7.9k). Market cap is less than US$10m (UK£2.48m market cap, or US$3.28m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).New Risk • Dec 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$8.0k). Market cap is less than US$10m (UK£4.14m market cap, or US$5.53m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding).공시 • Oct 14Incanthera plc, Annual General Meeting, Nov 07, 2025Incanthera plc, Annual General Meeting, Nov 07, 2025. Location: the offices of gateley plc, 1 paternoster square, ec4m 7dx, london United Kingdom공시 • Jul 02Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million.Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 14,514,286 Price\Range: £0.035 Transaction Features: Subsequent Direct ListingNew Risk • Apr 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.31m (US$9.48m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£7.31m market cap, or US$9.48m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).New Risk • Dec 19New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£2.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£6.14m market cap, or US$7.75m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).더 많은 업데이트 보기Recent updatesNew Risk • Jun 29New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$7.9k). Market cap is less than US$10m (UK£2.48m market cap, or US$3.28m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).New Risk • Dec 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$8.0k). Market cap is less than US$10m (UK£4.14m market cap, or US$5.53m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding).공시 • Oct 14Incanthera plc, Annual General Meeting, Nov 07, 2025Incanthera plc, Annual General Meeting, Nov 07, 2025. Location: the offices of gateley plc, 1 paternoster square, ec4m 7dx, london United Kingdom공시 • Jul 02Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million.Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 14,514,286 Price\Range: £0.035 Transaction Features: Subsequent Direct ListingNew Risk • Apr 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.31m (US$9.48m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£7.31m market cap, or US$9.48m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).New Risk • Dec 19New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£2.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£6.14m market cap, or US$7.75m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).New Risk • Nov 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£6.43m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Negative equity (-UK£565k). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (UK£6.43m market cap, or US$8.06m).New Risk • Oct 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 52% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£565k). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Market cap is less than US$100m (UK£26.5m market cap, or US$34.8m).공시 • Sep 26Incanthera plc, Annual General Meeting, Oct 17, 2024Incanthera plc, Annual General Meeting, Oct 17, 2024. Location: the offices of gateley plc, 1 paternoster square, ec4m 7dx, london United KingdomNew Risk • Jul 08New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£667k). Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (UK£28.3m market cap, or US$36.3m).공시 • Dec 20Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.8 million.Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.8 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,428,571 Price\Range: £0.07 Transaction Features: Subsequent Direct ListingNew Risk • Dec 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£214k). Revenue is less than US$1m. Market cap is less than US$10m (UK£5.51m market cap, or US$7.03m). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Oct 05New major risk - Negative shareholders equityThe company has negative equity. Total equity: -UK£214k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£453k free cash flow). Negative equity (-UK£214k). Revenue is less than US$1m. Market cap is less than US$10m (UK£5.01m market cap, or US$6.09m). Minor Risk Shareholders have been diluted in the past year (3.3% increase in shares outstanding).공시 • Oct 05Incanthera plc, Annual General Meeting, Nov 08, 2023Incanthera plc, Annual General Meeting, Nov 08, 2023, at 12:00 Coordinated Universal Time. Location: Gateley Plc, Ship Canal House, 98 King Street Mancehster United KingdomNew Risk • Jun 09New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£599k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (UK£5.18m market cap, or US$6.52m). Minor Risks Latest financial reports are more than 6 months old (reported September 2022 fiscal period end). Shareholders have been diluted in the past year (6.8% increase in shares outstanding).공시 • Sep 02Incanthera plc, Annual General Meeting, Sep 27, 2022Incanthera plc, Annual General Meeting, Sep 27, 2022, at 10:00 Coordinated Universal Time. Location: Ship Canal House, 98 King Street Manchester, M2 4WU Manchester United KingdomBoard Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Senior Independent Director Alan Warrander was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.주주 수익률INCGB PharmaceuticalsGB 시장7D-5.4%6.1%0.2%1Y-53.3%33.5%18.1%전체 주주 수익률 보기수익률 대 산업: INC은 지난 1년 동안 33.5%의 수익을 기록한 UK Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: INC은 지난 1년 동안 18.1%를 기록한 UK 시장보다 저조한 성과를 냈습니다.주가 변동성Is INC's price volatile compared to industry and market?INC volatilityINC Average Weekly Movement18.2%Pharmaceuticals Industry Average Movement5.4%Market Average Movement5.4%10% most volatile stocks in GB Market10.9%10% least volatile stocks in GB Market3.0%안정적인 주가: INC의 주가는 지난 3개월 동안 UK 시장보다 변동성이 컸습니다.시간에 따른 변동성: INC의 주간 변동성(18%)은 지난 1년 동안 안정적이었지만 UK 종목 중 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트20108Stuart Robertsonwww.incanthera.com피부과 및 종양학 치료제 회사인 Incanthera plc는 다양한 적응증을 위한 피부과 제형 및 전달 기술에 중점을 두고 있습니다. Skin + CELL이라는 브랜드명으로 스킨케어 제품을 개발합니다. 2010년에 설립되었으며 영국 맨체스터에 본사를 두고 있습니다.더 보기Incanthera plc 기초 지표 요약Incanthera의 순이익과 매출은 시가총액과 어떻게 비교됩니까?INC 기초 통계시가총액UK£2.48m순이익 (TTM)-UK£2.26m매출 (TTM)UK£6.00k402.3x주가매출비율(P/S)-1.1x주가수익비율(P/E)INC는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표INC 손익계산서 (TTM)매출UK£6.00k매출원가UK£91.00k총이익-UK£85.00k기타 비용UK£2.18m순이익-UK£2.26m최근 보고된 실적Sep 30, 2025다음 실적 발표일해당 없음주당순이익(EPS)-0.016총이익률-1,416.67%순이익률-37,750.00%부채/자본 비율0%INC의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/29 21:24종가2026/06/29 00:00수익2025/09/30연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Incanthera plc는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Martin HallHardman & Co.
New Risk • Jun 29New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$7.9k). Market cap is less than US$10m (UK£2.48m market cap, or US$3.28m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).
New Risk • Dec 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$8.0k). Market cap is less than US$10m (UK£4.14m market cap, or US$5.53m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding).
공시 • Oct 14Incanthera plc, Annual General Meeting, Nov 07, 2025Incanthera plc, Annual General Meeting, Nov 07, 2025. Location: the offices of gateley plc, 1 paternoster square, ec4m 7dx, london United Kingdom
공시 • Jul 02Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million.Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 14,514,286 Price\Range: £0.035 Transaction Features: Subsequent Direct Listing
New Risk • Apr 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.31m (US$9.48m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£7.31m market cap, or US$9.48m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).
New Risk • Dec 19New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£2.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£6.14m market cap, or US$7.75m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).
New Risk • Jun 29New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$7.9k). Market cap is less than US$10m (UK£2.48m market cap, or US$3.28m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).
New Risk • Dec 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.4m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (UK£6.0k revenue, or US$8.0k). Market cap is less than US$10m (UK£4.14m market cap, or US$5.53m). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding).
공시 • Oct 14Incanthera plc, Annual General Meeting, Nov 07, 2025Incanthera plc, Annual General Meeting, Nov 07, 2025. Location: the offices of gateley plc, 1 paternoster square, ec4m 7dx, london United Kingdom
공시 • Jul 02Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million.Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.508 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 14,514,286 Price\Range: £0.035 Transaction Features: Subsequent Direct Listing
New Risk • Apr 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.31m (US$9.48m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£7.31m market cap, or US$9.48m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).
New Risk • Dec 19New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£2.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.8m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (UK£6.14m market cap, or US$7.75m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).
New Risk • Nov 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£6.43m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Negative equity (-UK£565k). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (UK£6.43m market cap, or US$8.06m).
New Risk • Oct 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 52% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£565k). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Market cap is less than US$100m (UK£26.5m market cap, or US$34.8m).
공시 • Sep 26Incanthera plc, Annual General Meeting, Oct 17, 2024Incanthera plc, Annual General Meeting, Oct 17, 2024. Location: the offices of gateley plc, 1 paternoster square, ec4m 7dx, london United Kingdom
New Risk • Jul 08New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£667k). Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (UK£28.3m market cap, or US$36.3m).
공시 • Dec 20Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.8 million.Incanthera plc has completed a Follow-on Equity Offering in the amount of £0.8 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,428,571 Price\Range: £0.07 Transaction Features: Subsequent Direct Listing
New Risk • Dec 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£214k). Revenue is less than US$1m. Market cap is less than US$10m (UK£5.51m market cap, or US$7.03m). Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Oct 05New major risk - Negative shareholders equityThe company has negative equity. Total equity: -UK£214k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£453k free cash flow). Negative equity (-UK£214k). Revenue is less than US$1m. Market cap is less than US$10m (UK£5.01m market cap, or US$6.09m). Minor Risk Shareholders have been diluted in the past year (3.3% increase in shares outstanding).
공시 • Oct 05Incanthera plc, Annual General Meeting, Nov 08, 2023Incanthera plc, Annual General Meeting, Nov 08, 2023, at 12:00 Coordinated Universal Time. Location: Gateley Plc, Ship Canal House, 98 King Street Mancehster United Kingdom
New Risk • Jun 09New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£599k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (UK£5.18m market cap, or US$6.52m). Minor Risks Latest financial reports are more than 6 months old (reported September 2022 fiscal period end). Shareholders have been diluted in the past year (6.8% increase in shares outstanding).
공시 • Sep 02Incanthera plc, Annual General Meeting, Sep 27, 2022Incanthera plc, Annual General Meeting, Sep 27, 2022, at 10:00 Coordinated Universal Time. Location: Ship Canal House, 98 King Street Manchester, M2 4WU Manchester United Kingdom
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Senior Independent Director Alan Warrander was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
